Anixa Biosciences Inc
ANIXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for ANIX. That does not mean none is planned.
Get an email about ANIX's next catalysts
Track Anixa Biosciences (ANIX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
2 upcoming events in our data (conference, earnings).See the timeline
2 upcoming, 0 past
Conference Presentation - Ovarian cancer CAR-T
For Ovarian cancer. Anixa Biosciences announced that Dr. Robert Wenham, principal investigator of its Phase 1 ovarian cancer CAR-T trial at Moffitt Cancer Center, will present at the ESMO Immuno-Oncology & Advanced Therapies Congress 2026 in London on December 14.
SourceANIX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.08 | FQ end Oct/2026 | Call: tbd
Market Overview
Stock performance and key metrics
No drugs found in this phase.
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
When is Anixa Biosciences Inc's next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Anixa Biosciences Inc (ANIX) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track ANIX biotech catalysts?β
Add ANIX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Anixa Biosciences Inc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
